EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
1.4.3.22 | adenosine 3',5'-AMP | - |
Sus scrofa | |
1.4.3.22 | amiloride | diuretic drug, competitive vs. agmatine and putrescine oxidation | Sus scrofa | |
1.4.3.22 | clonidine | antihypertensive drug, competitive vs. agmatine and putrescine oxidation | Sus scrofa | |
1.4.3.22 | gabexate mesylate | anti coagulant drug, competitive vs. agmatine and putrescine oxidation | Sus scrofa |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
1.4.3.22 | Sus scrofa | - |
- |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.4.3.22 | RCH2NH2 + H2O + O2 | - |
Sus scrofa | RCHO + NH3 + H2O2 | - |
? |
EC Number | Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|---|
1.4.3.22 | 0.01 | - |
adenosine 3',5'-AMP | - |
Sus scrofa | |
1.4.3.22 | 0.027 | - |
gabexate mesylate | - |
Sus scrofa | |
1.4.3.22 | 0.9 | - |
clonidine | - |
Sus scrofa |